Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Mericq, Veronica / Ogata, Tsutomu / Toppari, Jorma

12 Issues per year


IMPACT FACTOR 2017: 1.086

CiteScore 2017: 1.07

SCImago Journal Rank (SJR) 2017: 0.465
Source Normalized Impact per Paper (SNIP) 2017: 0.580

Online
ISSN
2191-0251
See all formats and pricing
More options …
Volume 29, Issue 4

Issues

Evaluating health risk using a continuous metabolic syndrome score in obese children

Michelle Battista Hesse
  • Corresponding author
  • Department of Health Sciences, James Madison University, 801 Carrier Drive, MSC 4301, Harrisonburg, VA 22807, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Gregory Young / Robert D. Murray
Published Online: 2015-12-15 | DOI: https://doi.org/10.1515/jpem-2015-0271

Abstract

Background: The metabolic syndrome (MS) in pediatrics is controversial. Rather than a dichotomous scale, a continuous metabolic syndrome score (cMets) has been proposed to evaluate MS. The aim of this study was to evaluate the utility of a cMets score among an ethnically diverse cohort of children with acanthosis nigricans (AN).

Methods: A retrospective chart review was used to extract clinical and laboratory information on a cohort of obese children. Criteria for MS components and the cMets score were established using published guidelines. Multiple linear regression evaluated the effect of AN status on MS and cMets. Fisher’s exact test compared the race differential on the presence or absence of MS component disorders.

Results: MS diagnosis was non-significant when considering AN status (p=0.554) and ethnicity (p=0.431). Evaluation of the frequency of component disorders, revealed that Caucasians had significantly higher levels of abnormal triglycerides (TG) (35.1 vs. 10.3%; p<0.001), whereas African Americans had significantly higher homeostatic model assessment of insulin resistance (HOMA-IR) scores (51.3% vs. 22.3%; p<0.001). cMets was sensitive to identifying metabolic risk among Caucasians with AN, only (p=0.029).

Conclusions: This study found differences in health risk among an obese, ethnically diverse sample of children. cMets is a more sensitive marker of metabolic change compared with MS, especially when AN status and race are considered. cMets may pose an opportunity for the clinician to evaluate the interaction of health risks on the health status of obese children.

Keywords: acanthosis nigricans; childhood obesity; continuous metabolic syndrome score; metabolic risk; metabolic syndrome

References

  • 1.

    Ford ES, Li C. “Defining the metabolic syndrome in children and adolescents: will the real definition please stand up?” J Pediatr 2008;152:160–4.Web of ScienceGoogle Scholar

  • 2.

    Brambilla P, Lissau I, Flodmark CE, Morano LA, Widhalm K, Wabitsch M, et al. Metabolic risk factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes 2007;4:591–600.Web of ScienceGoogle Scholar

  • 3.

    Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 2008;5:7–17.Web of ScienceGoogle Scholar

  • 4.

    Battista M, Murray RD, Daniels SR. Use of the metabolic syndrome in pediatrics: a blessing and a curse. Semin Pediatr Surg 2009;18:136–43.Google Scholar

  • 5.

    Eisenmann JC, Laurson KR, DuBose KD, Smith BK, Donnelly JE. Construct validity of a continuous metabolic syndrome score in children. Diabetol Metab Syndr 2010;28:2–8.Web of ScienceGoogle Scholar

  • 6.

    Okosun IS, Lyn R, Davis-Smith M, Eriksen M, Seale P. Validity of a continuous metabolic risk score as an index for modeling metabolic syndrome in adolescents. Ann Epidemiol 2010;20:843–51.Google Scholar

  • 7.

    Center for Disease Control and Prevention. National Center for Health Statistics. n.d. January 2009. <http://www.cdc.gov/growthcharts>.

  • 8.

    Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children. Arch Dis Child 1966;46:613–35.Google Scholar

  • 9.

    Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 2007;150:12–17.Google Scholar

  • 10.

    Adolescents., National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and “The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents.” Pediatrics 2004;114:555–76.Google Scholar

  • 11.

    Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004;27:314–9.Google Scholar

  • 12.

    Keskin M, Kurtoglu S, Kendirici M, Atabek ME, Yazici Z. Homeostasis model assessment is more reliable than fasting glucose/insulin ration and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500–3.Google Scholar

  • 13.

    Daniels SR, Greer FR. and the Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008;122:198–208.Google Scholar

  • 14.

    Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW. Prevelence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adol Health 2001:28:372–6.Google Scholar

  • 15.

    Brickman WJ, Huang J, Silverman BL, Metzger BE. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr 2010:156:87–92.Web of ScienceGoogle Scholar

  • 16.

    Kong AS, Vanderbloemen L, Skipper B, Leggott J, Sebesta E, Glew R, et al. Acanthosis nigricans predicts the clustering of metabolic syndrome components in Hispanic elementary aged children. J Pediatr Endcrinol Metab 2012;25:1095–102.Web of ScienceGoogle Scholar

  • 17.

    Santoro N, Amato A, Grandone A, Brienza C, Savarese P, Tartaglione N, et al. Predicting metabolic syndrome in obese children and adolescents: look, measure and ask. Obesity Facts 2013;1:48–56.Web of ScienceGoogle Scholar

  • 18.

    Guran T, Turan S, Akcay T, Bereket A. Significance of acanthosis nigricans in childhood obesity. Paediatr and Child Health 2008;44:338–41.Web of ScienceGoogle Scholar

  • 19.

    Steward CA, Pate CJ, Peters EJ. Prevelence of acanthosis nigricans in an unselected population. Am J Med 1989;87:269–72.Google Scholar

  • 20.

    Bell RA, Mayer-Davis EJ, Beyer JW, D’Augostino R Jr, Imperatore G, Lawrence JM, et al. Diabetes in non-Hispanic white youth: prevalence, incidence and clinical characteristics: the SEARCH for diabetes in youth study. Diabetes Care 2009;32:S102–11.Google Scholar

  • 21.

    Mayer Davis EJ, Beyer J, Bell RA, Dabelea D, D’Augustino R Jr, Imperatore G, et al. Diabetes in African American youth: prevalence, incidence and clinical characteristics: the SEARCH for diabetes in youth study. Diabetes Care 2009;32:112–22.Google Scholar

  • 22.

    Weiss R, Dziura JD, Burgert TS, Taksali SE, Tamborlane WV, Caprio S. Racial differences in beta cell adaptation to insulin resistance in obese children and adolescents. Diabetologia 2006;49:571–9.Google Scholar

  • 23.

    Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in African American children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002;51:3014–9.Google Scholar

  • 24.

    Lee S, Gungor N, Bacha F, Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care 2007;30:2091–7.Web of ScienceGoogle Scholar

  • 25.

    Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in white and blacks. Circulation 2005;112:32–8.Google Scholar

  • 26.

    Giannini C, Santoro N, Caprio S, Kim G, Lartaud D, Shaw M, et al. Association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 2011;34:1869–74.Web of ScienceGoogle Scholar

  • 27.

    Hannon TS, Gupta S, Li Z, Eckert G, Carroll AE, Pratt JH, et al. The effect of body mass index on blood pressure varies by race among obese children. J Pediatr Endocrinol Metab 2015;28:533–8.Web of ScienceGoogle Scholar

  • 28.

    Freedman DS, Wnag J, Thornton JC, Mei Z, Pierson RN, Dietz WH, et al. Racial differences in body fatness among children and adolescents. Obesity 2008;16:1105–11.Web of ScienceGoogle Scholar

  • 29.

    Goran MI, Bergman RN, Gower BA. Influence of total vs. viceral fat on insulin action and secretion in African American and white children. Obes Res 2001;9:423–31.Google Scholar

  • 30.

    Liska D, Dufour S, Zern TL, Cali AM, Cziura J, Shulman GI, et al. Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents. PLoS ONE 2007;2:e569.CrossrefWeb of ScienceGoogle Scholar

  • 31.

    Gruson E, Montaye M, Kee F, Wagner A, Bingham A, Ruidavets JB, et al. Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart 2010;96:136–40.Web of ScienceGoogle Scholar

  • 32.

    Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012;126:1301–13.Google Scholar

  • 33.

    Alvey NJ, Pedley A, Rosenquist KJ, Massaro JM, O’Donnell CJ, Hoffmann U, et al. Association of fat density with subclinical atherosclerosis. J Am Heart Assoc 2014;3:1–8.Google Scholar

  • 34.

    Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39–48.Google Scholar

  • 35.

    Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents:race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 2003;88:2534–40.Google Scholar

  • 36.

    Osei K. Metabolic syndrome in blacks: are the criteria right? Curr Diab Rep 2010;10:199–208.Google Scholar

  • 37.

    Ten S, Bhangoo A, Ramchandani N, Mueller C, Vogiatzi M, New M, et al. Characterization of insulin resistance syndrome in children and young adults. When to screen for prediabetes? J Pediatr Endcrinol Metab 2007;20:989–1000.Google Scholar

  • 38.

    Executive summary: Standards of medical care in diabetes-2014. Diabetes Care 2014;37:S14–S80.Google Scholar

  • 39.

    Ice CL, Murphy E, Minor VE, Neal WA. Metabolic syndrome in fifth grade children with acanthosis nigricans: results from the CARDIAC project. World J Pediatr 2009;5:23–30.Web of ScienceGoogle Scholar

  • 40.

    Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119:628–47.Google Scholar

About the article

Received: 2015-07-07

Accepted: 2015-11-04

Published Online: 2015-12-15

Published in Print: 2016-04-01


Citation Information: Journal of Pediatric Endocrinology and Metabolism, Volume 29, Issue 4, Pages 451–458, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2015-0271.

Export Citation

©2016 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Cézane Priscila Reuter, Miria Suzana Burgos, Cláudia Daniela Barbian, Jane Dagmar Pollo Renner, Silvia Isabel Rech Franke, and Elza Daniel de Mello
European Journal of Pediatrics, 2018
[2]
Ramin Heshmat, Motahar Heidari, Hanieh-Sadat Ejtahed, Mohammad Esmaeil Motlagh, Armita Mahdavi-Gorab, Hasan Ziaodini, Majzoubeh Taheri, Gita Shafiee, Shaghayegh Beshtar, Mostafa Qorbani, and Roya Kelishadi
Diabetology & Metabolic Syndrome, 2017, Volume 9, Number 1
[3]
Hyo-Kyoung Nam, Hye Ryun Kim, Young-Jun Rhie, and Kee-Hyoung Lee
Journal of Pediatric Endocrinology and Metabolism, 2017, Volume 30, Number 5
[4]
Keum Ji Jung, Yon Ho Jee, and Sun Ha Jee
Asia Pacific Journal of Public Health, 2017, Volume 29, Number 2, Page 122
[5]
Chiara Mameli, Gian Vincenzo Zuccotti, Carla Carnovale, Erica Galli, Pilar Nannini, Davide Cervia, and Cristiana Perrotta
Pharmacological Research, 2017, Volume 119, Page 99

Comments (0)

Please log in or register to comment.
Log in